BellaSeno and Charité – Universitätsmedizin Berlin Collaborate Under BMBF-Funded SyMBoD Consortium
Development of absorbable implants for the personalized treatment of bone defects in patients with diabetes BellaSeno responsible for high resolution, medical-grade scaffold manufacturing under ISO 13485 BellaSeno GmbH, a company developing absorbable scaffolds using additive manufacturing technologies, today announced a Mehr